Navigation Links
Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results
Date:2/23/2010

general and administrative expenses 89,674 76,593 312,205 298,792 ------ ------ ------- ------- Combined collaboration commercial profit $115,573 $84,281 $441,135 $338,667 ======== ======= ======== ======== Onyx's share of collaboration commercial profit $57,787 $42,141 $220,567 $169,334 Reimbursement of Onyx's shared marketing expenses 7,435 6,415 23,514 22,185 Royalty revenue 2,095 1,094 6,309 2,824 ----- ----- ----- ----- Revenue from collaboration agreement $67,317 $49,650 $250,390 $194,343 ======= ======= ======== ========
    
    
                           ONYX PHARMACEUTICALS, INC.
             RECONCILIATION OF GAAP TO NON-GAAP NET INCOME (LOSS)
                  (In thousands, except per share amounts)
                                 (unaudited)
                                             
                                         Three Months           Year 
                                            Ended               Ended
                                         December 31,        December 31,
                                       -----------------   -----------------
                                        2009       2008     2009       2008  
                                       ------     ------   ------     ------
    GAAP net income (loss) 
     per share - basic                $(0.09)   $(0.53)   $ 0.27    $ 0.03
    GAAP net income (loss) 
     per share - diluted (4)          $(0.09)   $(0.53)   $ 0.27    $ 0.03
                                             
    GAAP net income (loss)           $(5,509) $(30,187)  $16,161    $1,948
    Non-GAAP adjustments:  
'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
2. Jazz Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on March 3, 2010
3. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
4. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
5. Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains
6. Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks
7. Endo Pharmaceuticals Reports Strong Fourth Quarter and Full-Year 2009 Financial Results: Provides 2010 Financial Guidance
8. Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
9. Jazz Pharmaceuticals Announces FDA Acceptance of its New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia
10. Transdel Pharmaceuticals Announces Management Reorganization
11. Merz Pharmaceuticals Introduces New Mederma(R) Stretch Marks Therapy Now Available in Drugstores Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... YORK , May 22, 2015 ... of the $13 billion global cardiac rhythm management ... Information.  Kalorama found that Medtronic, St. Jude Medical, ... command 80% of this market segment. The healthcare ... Device Markets , uses 2015 as a base ...
(Date:5/22/2015)... and KING OF PRUSSIA, Pa. , ... (NHF) has awarded CSL Behring its 2015 Corporate ... commitment to advancing science and improving the care of the ... Perreault , CEO and Managing Director, CSL Limited, during the ... on May 21. "The National Hemophilia ...
(Date:5/22/2015)... , May 20, 2015 Research ... of the "Guide to Prepare Application Dossiers ... China (2014 Edition) " report to their ... is one of segment market of the most ... overseas medical device manufacturers and producers to penetrate ...
Breaking Medicine Technology:Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3
(Date:5/22/2015)... Washington, DC (PRWEB) May 22, 2015 ... Howard University Hospital’s world-renowned surgical oncologist, Dr. LaSalle D. ... celebration. , The luncheon began after Grand Rounds in ... Delores Leffall, waited anxiously outside the auditorium, trying to ... hear him, but if he sees me, he’ll know ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 According to a ... all generations are equally as likely to worry about what ... 75% Gen X, 77% Boomers, 69% Silent Generation), which may ... they are scared of aging, particularly Millennials (47%), Gen X’ers ... Harris Poll in April, 2015 among more than 2,000 U.S. ...
(Date:5/22/2015)... May 22, 2015 According to Berks ... for drug related death, totaling almost 2,500 confirmed drug deaths, ... by state officials, totals 2,489 deaths stemming from legal and ... Pennsylvania loses seven people every day to fatal overdoses or ... singled out as one of the most rife with drug ...
(Date:5/22/2015)... VA (PRWEB) May 22, 2015 sweetFrog Enterprises, ... location in Jacksonville, Texas. Jacksonville is now the 16th sweetFrog ... yogurt chain was listed as #22 on the Inc. 500 ... “I have lived and worked in East Texas for 20 ... Brad Anderson, owner of the Jacksonville, and nearby Palestine, sweetFrog ...
(Date:5/22/2015)... Ticket Down is a reputable source for ... Eastern Conference Finals Tickets . All seating for the ... the ticket listing. , For the first time in ... of the Eastern Conference. One of the original franchises in ... and downs over the years, but the excitement level for ...
Breaking Medicine News(10 mins):Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3
... (HealthDay News) -- People with disabilities need to be ... of emergencies such as fires, floods, tornadoes and hurricanes, ... with disabilities are more complicated than those for able-bodied ... other natural disasters, persons with disabilities need to consider ...
... HealthDay Reporter , WEDNESDAY, June 6 (HealthDay News) -- When a ... it,s either very good or very bad news. ... drug, the results were so impressive that the trial,s independent data ... the study participants who were taking placebos. The drug, ...
... woman,s blood stream contains not only her own cells, but a ... remain in her internal organs long after the baby is born. ... understanding their potential effects on a mother,s long-term health. For example, ... it is unknown whether the cells are helping to destroy the ...
... a theoretical model to simulate the evolution of highly proliferating ... frequency electric field. The research, by Alexander Iomin from ... to be published in EPJ E . In another ... of treatment by targeting the outer area of the tumour. ...
... Exercise helps to alleviate pain related to nerve damage ... suggests an experimental study in the June issue of ... International Anesthesia Research Society (IARS). The results support ... pain, and suggest that it may work by reducing ...
... 31 (HealthDay News) -- Taking the arthritis drug methotrexate in ... injection for the long-term treatment of children with juvenile rheumatoid ... also have a similar incidence of side effects, researchers said ... medication as a pill instead of having to put up ...
Cached Medicine News:Health News:New Drug Effective for Rare Genetic Skin Cancer: Studies 2Health News:New Drug Effective for Rare Genetic Skin Cancer: Studies 3Health News:How does exercise affect nerve pain? 2Health News:For Juvenile Arthritis, Pill May Work as Well as Needle 2
... and CVA for CELL-DYN are assayed linearity ... calibration and to verify patient reportable range ... kits also measure the linear performance of ... kits have customized ranges appropriate for each ...
... is a nucleated red blood cell (nRBC) control ... Coulter LH 750/LH 755 hematology analyzer in its ... for the Coulter LH 750/LH 755. nRBC-Chex for ... cap-pierceable vials. nRBC-Chex for LH has a 75-day ...
... negative whole blood control to test for ... tests and hemoglobin electrophoresis. Sickle-Chex is compatible ... solubility kits. Sickle-Chex is packaged in a ... dispenses an accurate sample volume. No pipeting ...
... Proprietary EX.P.R.T. Release Technology ... No stent shortening,, Unique anatomically designed ... the carotid bifurcation,, 0.014 Rapid Exchange ... profile and flexible atraumatic tip,, Radiopaque ...
Medicine Products: